Vaxneuvance 0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FKRXB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,622
Award facts
- Contract value 100% obligated
- $9,622.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,622.00 to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 mL syringes on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
Vaxneuvance is a pneumococcal vaccine indicated for the prevention of invasive pneumococcal disease in adults. This procurement supports the federal government's medical supply needs for military and veteran healthcare systems. AmerisourceBergen Drug Corp's extensive portfolio of federal contracts demonstrates its capability to fulfill specialized pharmaceutical requirements across multiple therapeutic domains. The company's role as a critical pharmaceutical vendor for the Defense Logistics Agency underscores its significance in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DB26FKRXB?
SPE2DB26FKRXB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FKRXB worth?
The government has obligated $9,622 on SPE2DB26FKRXB.
Is contract SPE2DB26FKRXB an order under another contract?
Yes. SPE2DB26FKRXB is a delivery order under SPE2DB24D3014, an indefinite delivery contract.
Was contract SPE2DB26FKRXB competed?
The extent of competition for SPE2DB26FKRXB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award